Cargando…
Preliminary clinical experience applying donor-derived cell-free DNA to discern rejection in pediatric liver transplant recipients
Donor-derived cell-free DNA (dd-cfDNA) has been of major interest recently as a non-invasive marker of graft injury, but has not yet been extensively tested in children. From May to September in 2019, a total of 76 pediatric patients receiving a liver graft were enrolled and there were 27 patients e...
Autores principales: | Zhao, Dong, Zhou, Tao, Luo, Yi, Wu, Cheng, Xu, Dongwei, Zhong, Chengpeng, Cong, Wenming, Liu, Qiang, Zhang, Jianjun, Xia, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807012/ https://www.ncbi.nlm.nih.gov/pubmed/33441886 http://dx.doi.org/10.1038/s41598-020-80845-6 |
Ejemplares similares
-
Repeat kidney transplant recipients with active rejection have elevated donor‐derived cell‐free DNA
por: Mehta, Shikha G., et al.
Publicado: (2018) -
Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients
por: Jordan, Stanley C., et al.
Publicado: (2018) -
Application of plasma donor-derived cell free DNA for lung allograft rejection diagnosis in lung transplant recipients
por: Ju, Chunrong, et al.
Publicado: (2023) -
Observed elevated donor‐derived cell free DNA in orthotopic heart transplant recipients without clinical evidence of rejection
por: Afzal, Aasim, et al.
Publicado: (2021) -
Coincidence of cellular and antibody mediated rejection in heart transplant recipients – preliminary report
por: Zakliczyński, Michał, et al.
Publicado: (2014)